Nanjing Leads closes series A for immuno-oncology programs

Nanjing Leads raised about RMB100 million ($14.9 million) in a series A

Read the full 126 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE